Search for: "Teva Pharmaceuticals" Results 1401 - 1420 of 1,430
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
18 May 2023, 8:01 am by John Elwood
Most surprisingly to me, the court denied review in Teva Pharmaceuticals USA, Inc. v. [read post]
6 Aug 2009, 11:24 pm
See Procter & Gamble Co. v Teva Pharms. [read post]
5 Oct 2023, 9:01 pm by renholding
For example, when the Antitrust Division recently announced DPAs with two pharmaceutical companies, Teva and Glenmark, we determined that a monetary penalty alone was not sufficient. [read post]
11 Mar 2019, 10:15 am by Scott Sternberg
By: Amber Barlow Garcia, Deutsch KerriganWhen a lawsuit is filed in state court but federal court is a proper forum, defendants often prefer to remove the case. [read post]
21 Jun 2018, 4:00 pm by Aurora Barnes
Teva Pharmaceuticals USA Inc. 17-1229 Issue: Whether, under the Leahy-Smith America Invents Act, an inventor’s sale of an invention to a third party that is obligated to keep the invention confidential qualifies as prior art for purposes of determining the patentability of the invention. [read post]
22 Nov 2010, 11:02 am by Christa Culver
, Inc.Amicus brief for Teva Pharmaceuticals, et al.Amicus brief for Securities Industry and Financial Markets Association, et al.Amicus brief for IntelAmicus brief for Facebook Inc., et al.Amicus brief for Electronic Frontier Foundation, et al.Amicus brief for CTIA - The Wireless AssociationAmicus brief for Apple Inc.Amicus brief for Acushnet, et al.Amicus brief for Thirty-Six ProfessorsPetitioner's reply Title: Tiffany (NJ) Inc. v. eBayDocket: 10-300Issue(s): Whether, under… [read post]
4 Feb 2015, 1:52 pm by Lawrence B. Ebert
In In re Cuozzo Speed Technologies, a split CAFC panel observedContrary to Cuozzo’s contention, we hold that we lackjurisdiction to review the PTO’s decision to institute IPR.We affirm the Board’s final determination, finding noerror in the Board’s claim construction under the broadestreasonable interpretation standard, the Board’s obviousnessdetermination, and the Board’s denial of Cuozzo’smotion to amend.The legal matter involved an inter partes review… [read post]
23 Jan 2024, 9:01 pm by renholding
In 2022, Teva Pharmaceutical Industries Ltd. also settled shareholder allegations related to the price-fixing scheme for $420 million. 7.) [read post]
28 Mar 2008, 6:00 am
- Anonymity of policy research group quoted on pharma patenting policy and stats: (Spicy IP),Thailand: More news/reactions on compulsory licenses: (Generic Pharmaceuticals & IP),US: Follow-on biologic drugs and patent law: A potential disconnect? [read post]
16 May 2008, 8:03 am
: (GenericsWeb), Europe: New EBA referral T 1319/04 regarding patentability of known medicament for new treatment of same illness: (IPKat), Europe: Patentability of biotechnology in Europe: (IAM), Europe: New EPO Enlarged Board case referrals: T1319/04 Dosage Regimen, T1242/06 Essential Biological Process: (Hal Wegner), Thailand: Compulsory licensing: Affordable health for Thailand thanks to Matrix Labs: (Spicy IP), Thailand: European Parliament set to reprimand Mandelson for… [read post]
24 Jun 2011, 3:25 pm by Christa Culver
”Certiorari stage documents:Opinion below (3d Circuit)Petition for certiorariBrief in oppositionPetitioners' supplemental briefRespondents' supplemental briefPetitioners' replyAmicus brief of TEVA Pharmaceuticals USA, Inc.Amicus brief of Consumer Federation of America et al.Amicus brief of Mylan Pharmaceuticals, Inc.Amicus brief of Apotex, Inc.Amicus Generic Pharmaceutical AssociationCVSG Information:Invited: March 28, 2011Filed: May 26, 2011… [read post]
20 Jun 2018, 5:00 pm by John Elwood
Teva Pharmaceuticals USA Inc., 17-1229, the bar section will be completely full on the day it is argued. [read post]
2 Mar 2012, 6:52 am by Bexis
PARISIAN TRANSCRIPTS 2.0 We had a number of people send us material after our first post with out list of deposition transcripts (and various other items) concerning the testimony of the extremely active plaintiffs’ side expert, Dr. [read post]
11 Apr 2008, 9:00 am
No problem…: Lundbeck A/S v Generics UK Ltd & Ors: (IPKat), Exelon (Rivastigmine Tartrate) – Dr Reddy’s and Novartis settle Exelon patent dispute: (Therapeutics Daily), GeneMaker – Codon Devices, Blue Heron Biotechnology settle patent suit over gene synthesis platform: (Patent Docs), Glucophage (Metformin) – Depomed settles patent litigation against IVAX: (SmartBrief), (IP Law360), (GenericsWeb), Lexapro (Escitalopram)… [read post]
22 Jan 2009, 2:06 am
As we reported yesterday, the California Supreme Court denied the petitions for review in Wyeth v. [read post]
17 Aug 2021, 5:09 pm by Eugene Volokh
[ASU loses, even though the defendant “stopped participating in this action after his answer was stricken” “for litigation misconduct”: “[A]a reasonably prudent consumer would not be deceived or confused into believing that ASU was the ‘source or origin’ of the posts and messages emanating from the ‘asu_covid.parties. [read post]
15 Oct 2018, 7:05 am by Deborah Heller
Justice Kavanaugh being seated prior to the second week of oral arguments in October means that most of the cases on the docket in the October Term will be heard by a complete Court of 9 Justices; thus avoiding the dreaded 4-4 split. [read post]